Gane, Edward J <br/><br/>
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial.  [electronic resource] 

 -  Lancet (London, England)  Oct 2010 
 - 1467-75 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(10)61384-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Cyclopropanes<br/>Deoxycytidine--administration & dosage<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Isoindoles<br/>Lactams--administration & dosage<br/>Lactams, Macrocyclic<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Proline--analogs & derivatives<br/>RNA, Viral--blood<br/>Recombinant Proteins<br/>Sulfonamides--administration & dosage<br/>Viral Nonstructural Proteins--antagonists & inhibitors